We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 53.44%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+53.44%
3 Year Est. Return
+163.58%
5 Year Est. Return
+226.76%
10 Year Est. Return
+868.14%
AUM
$1.26B
AUM Growth
+$311M
Cap. Flow
+$182M
Cap. Flow %
14.51%
Top 10 Hldgs %
68.74%
Holding
79
New
7
Increased
13
Reduced
23
Closed
16

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$9.92M
2
AMZN icon
Amazon
AMZN
+$9.16M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$6.43M
4
NEM icon
Newmont
NEM
+$5.04M
5
CLF icon
Cleveland-Cliffs
CLF
+$4.87M

Sector Composition

Rank Sector Weight
1 Financials 10.05%
2 Technology 8.15%
3 Communication Services 7.42%
4 Materials 5.51%
5 Consumer Staples 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCX icon
51
PUT
Freeport-McMoran
FCX
$88.5B
$2.09M 0.17%
50,000
-50,000
-50% -$1.9M
CRSP icon
52
CRISPR Therapeutics
CRSP
$4.66B
$1.43M 0.11%
18,876
RARE icon
53
Ultragenyx Pharmaceutical
RARE
$2.67B
$1.34M 0.11%
15,885
DAL icon
54
Delta Air Lines
DAL
$56.6B
$1.06M 0.08%
27,029
AMC icon
55
PUT
AMC Entertainment Holdings
AMC
$2.12B
$816K 0.07%
3,000
-6,000
-67% -$2.11M
FSR
56
PUT
DELISTED
Fisker Inc.
FSR
$787K 0.06%
+50,000
New +$865K
EDIT icon
57
Editas Medicine
EDIT
$416M
$765K 0.06%
28,797
SGMO
58
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$605K 0.05%
80,650
ADAP
59
DELISTED
Adaptimmune Therapeutics
ADAP
$434K 0.03%
115,602
CLLS
60
Cellectis
CLLS
$286M
$413K 0.03%
50,907
WVE icon
61
Wave Life Sciences
WVE
$1.15B
$134K 0.01%
42,722
BLUE
62
DELISTED
bluebird bio
BLUE
$112K 0.01%
561
-305
-35% -$72K
ABEO icon
63
Abeona Therapeutics
ABEO
$349M
$31K ﹤0.01%
3,696
ADVM
64
DELISTED
Adverum Biotechnologies
ADVM
-18,862
Closed -$409K
AMC icon
65
CALL
AMC Entertainment Holdings
AMC
$2.12B
-5,000
Closed -$1.9M
FNF icon
66
Fidelity National Financial
FNF
$14B
-433,454
Closed -$18.9M
GME icon
67
PUT
GameStop
GME
$9.6B
-160,000
Closed -$7.02M
KSS icon
68
PUT
Kohl's
KSS
$2.09B
-50,000
Closed -$2.35M
MPT
69
CALL
Medical Properties Trust
MPT
$2.91B
-400,000
Closed -$8.03M
MPT
70
PUT
Medical Properties Trust
MPT
$2.91B
-200,000
Closed -$4.01M
PRAA icon
71
PRA Group
PRAA
$675M
-51,007
Closed -$2.15M
SPCE icon
72
CALL
Virgin Galactic
SPCE
$325M
-10,000
Closed -$5.06M
SRPT icon
73
Sarepta Therapeutics
SRPT
$1.73B
-15,706
Closed -$1.45M
UBER icon
74
CALL
Uber
UBER
$137B
-50,000
Closed -$2.24M
VMEO
75
DELISTED
Vimeo
VMEO
-11,600
Closed -$341K

Similar funds

WS Management's Q4 2021 Portfolio in Review

As of Q4 2021, WS Management held 79 positions worth $1.26B, up 33% from $945M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

WS Management deployed $182M of net new capital in Q4 2021, opening 7 new positions and adding to 13 existing holdings. Its largest new stake was Coursera: 95,266 shares worth $2.33M.

By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 17% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $62.5M trimmed.

  • WS Management's largest Q4 2021 buy was Coursera: 95,266 shares worth $2.33M.
  • WS Management added most to SPDR Gold Trust in Q4 2021, an estimated $9.92M increase.
  • WS Management's biggest Q4 2021 reduction was Alphabet (Google) Class A, cutting an estimated $62.5M.
  • WS Management fully exited Fidelity National Financial in Q4 2021, selling an estimated $18.9M.
  • WS Management's ten largest holdings make up 69% of its $1.26B portfolio in Q4 2021.
  • WS Management opened 7 new positions and closed 16 in Q4 2021.
  • WS Management's portfolio value rose 33% quarter-over-quarter to $1.26B.

Based on WS Management's 13F filing for Q4 2021, filed 11 Feb 2022.